Schizophrenia Research
Volume 77, Issue 2 , Pages 241-252 , 15 September 2005

Variations in differential gene expression patterns across multiple brain regions in schizophrenia

  • P. Katsel
    • ,
  • K.L. Davis
    • ,
  • J.M. Gorman
    • ,
  • V. Haroutunian

      Affiliations

    • Corresponding Author InformationCorresponding author. Psychiatry, Room 4F-33A, Bronx VA Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, United States. Tel.: +1 718 584 9000x6082; fax: +1 718 365 9622.

Received 20 January 2005 ,Revised 22 March 2005 ,Accepted 24 March 2005.

References 

  1. Andy OJ, Webster JS, Carranza J. Frontal lobe lesions and behavior. South Med. J. 1981;74:968–972
  2. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. 1996;92:217–231(Berl)
  3. Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J. Neurosci. Res. 2004;77:858–866
  4. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am. J. Psychiatry. 1990;147:1457–1462
  5. Baumann B, Bogerts B. The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr. Res. 1999;39:141–148
  6. Benes FM. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol. Psychiatry. 1999;46:589–599
  7. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 2000;31:251–269
  8. Benes FM, Todtenkopf MS, Vincent SL. Meta-analysis of nonpyramidal neuron (NP) loss in layer II in anterior cingulate cortex (ACCxII) from three studies of postmortem schizophrenic (SZ) brain. Abstr. - Soc. Neurosci. 1998;25:1296
  9. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry. 2001;50:395–406
  10. Blackwood DH, Ebmeier KP, Muir WJ, Sharp CW, Glabus M, Walker M, et al. Correlation of regional cerebral blood flow equivalents measured by single photon emission computerized tomography with P300 latency and eye movement abnormality in schizophrenia. Acta Psychiatr. Scand. 1994;90:157–166
  11. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, et al. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 2003;23:3807–3819
  12. Bogerts B. The temporolimbic system theory of positive schizophrenic symptoms. Schizophr. Bull. 1997;23:423–435
  13. Bonaventure P, Guo H, Tian B, Liu X, Bittner A, Roland B, et al. Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res. 2002;943:38–47
  14. Brown R, Colter N, Corsellis JA, Crow TJ, Frith CD, Jagoe R, et al. Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch. Gen. Psychiatry. 1986;43:36–42
  15. Buchsbaum MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr. Bull. 1990;16:379–389
  16. Byne W, Buchsbaum MS, Kemether E, Hazlett EA, Shinwari A, Siever L. MRI assessment of medial dorsal and pulvinar nuclei of the thalamus in schizophrenia and schizotypal personality disorder. Arch. Gen. Psychiatry. 2001;58:133–140
  17. Byne W, Buchsbaum MS, Mattiace LA, Hazlett EA, Kemether E, Elhakem SL, et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry. 2002;159:59–65
  18. Cannon TD, Thompson PM, van Erp TG, Toga AW, Poutanen VP, Huttunen M, et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2002;99:3228–3233
  19. Cannon TD, van Erp TG, Glahn DC. Elucidating continuities and discontinuities between schizotypy and schizophrenia in the nervous system. Schizophr. Res. 2002;54:151–156
  20. Catafau AM, Parellada E, Lomena FJ, Bernardo M, Pavia J, Ros D, et al. Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. J. Nucl. Med. 1994;35:935–941
  21. Copland C, Dracheva S, Davis K, Haroutunian L. Regional mRNA expression of myelination related genes in schizophrenia. Am. Coll. Neuropsychopharmacol. 2003;236:
  22. Copland C, Dracheva S, Davis KL, Haroutunian V. Regional mRNA expression of MAG isoforms in elderly schizophrenia patients. Soc. Neurosci. 2004;109.5
  23. Copland C, Weickert C, Kleinman J, Davis KL, Haroutunian V. Small myelin-associated glycoprotein (S-MAG) gene expression during normal human development and in elderly schizophrenia patients. Am. Coll. Neuropsychopharmacol.. 2004;
  24. Copland, C.M., Dracheva, S., Gorman, J.M., Davis, K.L., Haroutunian, V., 2004c. Regional myelin-related gene expression in elderly patients with schizophrenia. American Journal of Psychiatry—Submitted.
  25. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry. 2001;58:545–553
  26. Damasio H, Damasio AR. Appendix. In:  Damasio H,  Damasio AR editor. Lesion Analysis in Neuropsychology. New York: Oxford University Press; 1989;p. 184–221
  27. Davidson M, Haroutunian V. Cognitive impairment in geriatric schizophrenic patients: clinical and postmortem characterization. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;
  28. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof P, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arc. Gen. Psychiatry. 2003;60:443–456
  29. Dent GW, O'Dell DM, Eberwine JH. Gene expression profiling in the amygdala: an approach to examine the molecular substrates of mammalian behavior. Physiol. Behav. 2001;73:841–847
  30. Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J. Neurosci. Res. 2004;76:581–592
  31. Dracheva S, Marras SA, Elhakem SL, Kramer FR, Davis KL, Haroutunian V. N-Methyl-d-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am. J. Psychiatry. 2001;158:1400–1410
  32. Ebert D, Feistel H, Barocka A, Kaschka W, Mokrusch T. A test–retest study of cerebral blood flow during somatosensory stimulation in depressed patients with schizophrenia and major depression. Eur. Arch. Psychiatry Clin. Neurosci. 1993;242:250–254
  33. Flynn SW, Lang DJ, MacKay AL, Goghari V, Vavasour IM, Whittall KP, et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol. Psychiatry. 2003;8:811–820
  34. Fujii D, Ahmed I. Characteristics of psychotic disorder due to traumatic brain injury: an analysis of case studies in the literature. J. Neuropsychiatry Clin. Neurosci. 2002;14:130–140
  35. Fuster JM. Frontal lobe and cognitive development. J. Neurocytol. 2002;31:373–385
  36. Galasko D, Kwo-On-Yuen PF, Thal L. Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr. Clin. North Am. 1988;11:151–166
  37. Galfalvy HC, Erraji-Benchekroun L, Smyrniotopoulos P, Pavlidis P, Ellis SP, Mann JJ, et al. Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics. 2003;4:37
  38. Gaser C, Nenadic I, Volz HP, Buchel C, Sauer H. Neuroanatomy of “hearing voices”: a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia. Cereb. Cortex. 2004;14:91–96
  39. Goldman-Rakic PS. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol. Psychiatry. 1999;46:650–661
  40. Gur RE, Turetsky BI, Cowell PE, Finkelman C, Maany V, Grossman RI, et al. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry. 2000;57:769–775
  41. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:4746–4751
  42. Han ES, Wu Y, McCarter R, Nelson JF, Richardson A, Hilsenbeck SG. Reproducibility, sources of variability, pooling, and sample size: important considerations for the design of high-density oligonucleotide array experiments. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 2004;59:306–315
  43. Haroutunian V, Buxbaum J, Katsel P, Copland C, Dracheva S, Elhakem SL, et al. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia. Am. J. Med. Genet. 2003;122B:4
  44. Haroutunian V, Davis KL. Neuropathology of schizophrenia. In:  Breier A,  Tran PV,  Herrera J,  Bymaster F,  Tollefson GD editor. Current Issues in the Psychopharmacology of Schizophrenia. Baltimore: Williams and Wilkins; 2000;p. 57–70
  45. Haroutunian V, Davis KL. Issues and perspectives on brain tissue banking. Curr. Psychiatry Rep. 2002;4:233–234
  46. Haroutunian V, Davis KL. Pathophysiology of dementia. In:  Tasman A,  Kay J,  Lieberman J editor. Psychiatry. vol. 1:Chichester, England: John Wiley and Sons; 2003;p. 338–349
  47. Haroutunian V, Katsel P, Dracheva S, Copland C, Gorman JM, Davis KL. Myelinating glial cells in psychiatric disorders: myelin-related gene expression abnormalities in 17 cortical and subcortical regions in schizophrenia. Neuropsychopharmacology. 2004;29:S32
  48. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122:593–624
  49. Harrison PJ. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology. 2004;174:151–162(Berl)
  50. Harrison PJ, Burnet PW, Falkai P, Bogerts B, Eastwood SL. Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex. Schizophr. Res. 1997;26:93–102
  51. Harrison PJ, Eastwood SL. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 2001;11:508–519
  52. Highley JR, McDonald B, Walker MA, Esiri MM, Crow TJ. Schizophrenia and temporal lobe asymmetry. A post-mortem stereological study of tissue volume. Br. J. Psychiatry. 1999;175:127–134
  53. Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem. Res. 2002;27:1193–1200
  54. Hof PR, Haroutunian V, Friedrich VL, Byne W, Buitron C, Perl DP, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry. 2003;53:1075–1085
  55. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–264
  56. Katsel P, Davis KL, Haroutunian V. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int. Rev. Neurobiol. 2004;63:41–81
  57. Katsel P, Dracheva S, Copland CM, Gorman JM, Davis KL, Haroutunian V. Tight and adherens junctions genes of myelinating oligodendrocytes are downregulated in schizophrenia. Biol. Psychiatry. 2004;55:159S
  58. Kemether EM, Buchsbaum MS, Byne W, Hazlett EA, Haznedar M, Brickman AM, et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch. Gen. Psychiatry. 2003;60:983–991
  59. Konu O, Kane JK, Barrett T, Vawter MP, Chang R, Ma JZ, et al. Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res. 2001;909:194–203
  60. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry. 1998;172:110–120
  61. Lein ES, Zhao X, Gage FH. Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J. Neurosci. 2004;24:3879–3889
  62. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U. S. A. 2001;98:31–36
  63. Marsh L, Harris D, Lim KO, Beal M, Hoff AL, Minn K, et al. Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset. Arch. Gen. Psychiatry. 1997;54:1104–1112
  64. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, et al. MRI anatomy of schizophrenia. Biol. Psychiatry. 1999;45:1099–1119
  65. Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR, et al. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am. J. Psychiatry. 2001;158:1809–1817
  66. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 2002;22:2718–2729
  67. Miller BL, Lesser IM, Boone KB, Hill E, Mehringer CM, Wong K. Brain lesions and cognitive function in late-life psychosis. Br. J. Psychiatry. 1991;158:76–82
  68. Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, et al. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. U. S. A. 2002;99:4680–4685
  69. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53–67
  70. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry. 2001;6:293–301
  71. Pavlidis P, Noble WS. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol. 2001;2:RESEARCH0042
  72. Popken GJ, Bunney WE, Potkin SG, Jones EG. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 2000;97:9276–9280
  73. Powchik P, Davidson M, Haroutunian V, Gabriel SM, Purohit DP, Perl DP, et al. Postmortem studies in schizophrenia. Schizophr. Bull. 1998;24:325–341
  74. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry. 1998;55:205–211
  75. Raedler TJ, Knable MB, Weinberger DR. Schizophrenia as a developmental disorder of the cerebral cortex. Curr. Opin. Neurobiol. 1998;8:157–161
  76. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2002;57:127–138
  77. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry. 1998;55:215–224
  78. Roberts GW, Bruton CJ. Notes from the graveyard: neuropathology and schizophrenia. Neuropathol. Appl. Neurobiol. 1990;16:3–16
  79. Rubin P, Holm S, Madsen PL, Friberg L, Videbech P, Andersen HS, et al Regional cerebral blood flow distribution in newly diagnosed schizophrenia and schizophreniform disorder. Psychiatry Res. 1994;53:57–75
  80. Sagawa K, Kawakatsu S, Shibuya I, Oiji A, Morinobu S, Komatani A, et al. Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients. Schizophr. Res. 1990;3:241–246
  81. Selemon LD. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr. Bull. 2001;27:349–377
  82. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry. 1999;45:17–25
  83. Selemon LD, Rajkowska G. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr. Mol. Med. 2003;3:427–436
  84. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 1995;52:805–818
  85. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 1998;392:402–412
  86. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, et al Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N. Engl. J. Med. 1992;327:604–612
  87. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatry. 2004;161:882–888
  88. Stevens JR. An anatomy of schizophrenia?. Arch. Gen. Psychiatry. 1973;29:177–189
  89. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:11650–11655
  90. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798–805
  91. Torrey EF, Peterson MR. Schizophrenia and the limbic system. Lancet. 1974;2:942–946
  92. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH, Donovan DM, et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 2001;55:641–650
  93. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr. Res. 2002;58:11–20
  94. Weinberger DR. Neurodevelopmental prespectives in schizophrenia. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 1171–1184
  95. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry. 1999;45:395–402
  96. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal–limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am. J. Psychiatry. 1992;149:890–897
  97. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 1995;16:87–110
  98. Zirlinger M, Kreiman G, Anderson DJ. Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei. Proc. Natl. Acad. Sci. U. S. A. 2001;98:5270–5275

PII: S0920-9964(05)00131-3

doi: 10.1016/j.schres.2005.03.020

Schizophrenia Research
Volume 77, Issue 2 , Pages 241-252 , 15 September 2005

Article Tools